Molecular Marker Driven Trial Design (Educational Session)
- Sort by:
- Browse by:
- Free
- audio + slides
Statistical Issues in Identifying, Validating and Using Molecular Markers in Clinical Trials
Marc E. Buyse, Sc.D.
International Drug Development Institute, Ottignies, Belgium
- Free
- audio + slides
Multiple Markers-the FDA Perspective
Steven I. Gutman, M.D.
Food and Drug Administration, Rockville, MD
- Free
- audio + slides
Molecular Marker Driven Trial Design
Donald A. Berry, Ph.D.
UT M.D. Anderson Cancer Center, Houston, TX